According to Shin Nippon Biomedical Laboratories latest financial reports the cash on hand of 2395 is $74.03M, an increase of 50.54% to 2022. At the end of 2022 company had $49.18M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $74.03M | 50.54% |
2022 | $49.18M | -3.97% |
2021 | $51.21M | 38.80% |
2020 | $36.90M | 2.11% |
2019 | $36.14M | - |